Chinese Journal of Tissue Engineering Research ›› 2014, Vol. 18 ›› Issue (3): 329-334.doi: 10.3969/j.issn.2095-4344.2014.03.001

    Next Articles

In vivo osteogenesis by implanting dual gene activated nanobone putty

Zhang Yi, Sun Li, Jian Yue-kui, Hu Ru-yin, Tian Xiao-bin, Li Bo, Han Wei   

  1. Department of Orthopedics, Guizhou Provincial People’s Hospital, Guiyang 550002, Guizhou Province, Chinai
  • Online:2014-01-15 Published:2014-01-15
  • Contact: Tian Xiao-bin, Chief physician, Department of Orthopedics, Guizhou Provincial People’s Hospital, Guiyang 550002, Guizhou Province, China
  • About author:Zhang Yi, M.D., Associate chief physician, Department of Orthopedics, Guizhou Provincial People’s Hospital, Guiyang 550002, Guizhou Province, China
  • Supported by:

    the National Natural Science Foundation of China, No. 81060145; the Scientific Tackle Key Program of Guizhou Province, No. SY[2010]3057 ; the Special Assistance Fund of Guizhou Province, No. TZJF-2011-34; the Special Fund for Excellent Young Scientific Talents in Guizhou Province, No. [2011]30; the Fund of Guizhou Provincial Science and Technology Bureau, No. SYC2010J3113

Abstract:

BACKGROUND: The bone morphogenetic protein 2 (BMP2)/vascular endothelial growth factor (VEGF) dual gene activated nanobone putty has been constructed in the previous experiments.
OBJECTIVE: To investigate the effects of osteogenesis and osteogenic gene expression in mice by implanting BMP2/VEGF dual gene activated nanobone putty.
METHODS: Twenty-four Kunming mice (48 sides) were randomly divided into four groups. Animals in each group (12 samples) were injected different materials into the right thigh muscle pouches: nanobone putty+hBMP2/VEGF plasmid; nanobone putty+hBMP2 plasmid; blank plasmid+nanobone putty; nanobone putty only. The effects of osteogenesis were evaluated by radiography, histology and molecular biology analysis in 2, 4 weeks after operation.
RESULTS AND CONCLUSION: Bone-like tissues were observed in groups of nanobone putty+hBMP2/VEGF plasmid and nanobone putty+hBMP2 plasmid after operation. There was apparent BMP2 and VEGF mRNA expression in group of nanobone putty+hBMP2/VEGF plasmid. Group of nanobone putty+hBMP2/VEGF plasmid was significantly better than group of nanobone putty+hBMP2 plasmid in the alkaline phosphatase levels, the speed of osteogenesisas and amount of new bone (P < 0.05). Groups of blank plasmid+nanobone putty and nanobone putty had no obvious osteogenesis performance. Either BMP2/VEGF dual gene activated nanobone putty or BMP2 gene activated nanobone putty had the osteogenic ability in vivo. And the former was significantly enhanced in the speed and quality of osteogenesis.


中国组织工程研究杂志出版内容重点:生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程


全文链接:

Key words: biocompatible materials, nanoparticles, genes, bone morphogenetic proteins

CLC Number: